These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34176196)

  • 41. Impact of cyclosporin treatment on health-related quality of life of patients with alopecia areata.
    Lai VWY; Chen G; Sinclair R
    J Dermatolog Treat; 2021 Mar; 32(2):250-257. PubMed ID: 31389731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study.
    Zaher H; Gawdat HI; Hegazy RA; Hassan M
    Dermatology; 2015; 230(4):308-13. PubMed ID: 25765294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review.
    Dabek RJ; Roh DS; Ozdemir D; Austen WG; Bojovic B
    Cureus; 2019 Jun; 11(6):e4943. PubMed ID: 31453018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth Factors and Microneedling in Alopecia Areata: A Narrative Review.
    Almutlq MM; Bukhari AE
    Skin Appendage Disord; 2024 Apr; 10(2):92-98. PubMed ID: 38572186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ophiasis alopecia areata treated with microneedling.
    Asad U; Wallis D; Tarbox M
    Proc (Bayl Univ Med Cent); 2020 Jul; 33(3):413-414. PubMed ID: 32675968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety.
    Lai VWY; Chen G; Gin D; Sinclair R
    J Am Acad Dermatol; 2019 Sep; 81(3):694-701. PubMed ID: 31048013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of antihistamines in combination with topical corticosteroid and superficial cryotherapy for treatment of alopecia areata: A retrospective cohort study.
    Lee YB; Lee WS
    J Am Acad Dermatol; 2021 Apr; 84(4):1152-1154. PubMed ID: 32682023
    [No Abstract]   [Full Text] [Related]  

  • 48. Alopecia areata treated with topical and systemic brevilin A: A case series.
    Muscianese M; Magri F; Leoncini P; Fortuna MC; Caro G; Rossi A
    Dermatol Ther; 2021 Mar; 34(2):e14778. PubMed ID: 33438308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Method for describing patterns and distributions of alopecia areata which may be helpful for patient characterization and predicting prognosis.
    Lee H; Choe SJ; Lee WS
    J Dermatol; 2019 Aug; 46(8):739-740. PubMed ID: 31215678
    [No Abstract]   [Full Text] [Related]  

  • 50. Emerging Unconventional Therapies for Alopecia Areata.
    Atanaskova Mesinkovska N
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S32-S33. PubMed ID: 29273103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata.
    Akdogan N; Ersoy-Evans S; Doğan S; Atakan N
    Dermatol Ther; 2019 Nov; 32(6):e13118. PubMed ID: 31621150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata.
    Guttman-Yassky E; Nia JK; Hashim PW; Mansouri Y; Alia E; Taliercio M; Desai PN; Lebwohl MG
    Arch Dermatol Res; 2018 Oct; 310(8):607-614. PubMed ID: 30121698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of the alopecia areata symptom impact scale.
    Mendoza TR; Osei JS; Shi Q; Duvic M
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S51-2. PubMed ID: 24326557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.
    Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E
    JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of alopecia areata with 2940-nm fractional erbium:yttrium-aluminum-garnet laser.
    Tanakol A; Oba MC; Uzuncakmak TK; Askin O; Kutlubay Z
    Dermatol Ther; 2020 Nov; 33(6):e13978. PubMed ID: 32633447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata.
    Strazzulla LC; Avila L; Lo Sicco K; Shapiro J
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S21-S24. PubMed ID: 29273100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
    Morsy H; Maher R; Negm D
    J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alopecia areata treated with dimethyl fumarate: A case series.
    Muscianese M; Magri F; Leoncini PP; Fortuna MC; Caro G; Rossi A
    Dermatol Ther; 2020 Nov; 33(6):e14158. PubMed ID: 32888223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of photodynamic therapy with 5-aminolaevulinic acid and microneedling in the treatment of alopecia areata resistant to conventional therapies: our experience with 41 patients.
    Giorgio CM; Babino G; Caccavale S; Russo T; De Rosa AB; Alfano R; Fulgione E; Argenziano G
    Clin Exp Dermatol; 2020 Apr; 45(3):323-326. PubMed ID: 31469914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Five-year experience in the treatment of alopecia areata with DPC.
    El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.